Tech Company Financing Transactions
Envisia Therapeutics Funding Round
Envisia Therapeutics closed a $10.1 million Series A funding round on 3/18/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
3/18/2016
Transaction Type
Venture Equity
Amount
$10,117,521
Round
Series A
Investors
Proceeds Purpose
Total amount sold includes the value of cancelled indebtedness formerly held by certain purchasers in the aggregate principal amount of $4,944,000. Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
P.O. Box 110065
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
As many as 285 million people suffer from disease-related visual impairments and blindness,1 but an estimated 80 percent of these visual impairments are actually preventable2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Eric Linsley
President
Benjamin Yerxa
VP - Bus. Development
Tomas Navratil
Browse more venture capital transactions:
Prev: 3/18/2016: Pieces Technologies venture capital transaction
Next: 3/18/2016: X-NAV Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs